Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03722394 · ClinicalTrials.gov registry record · NA
Pain Neuroscience Education for Acute and Sub-Acute Low Back Pain
A NA study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03722394: Completed NA study, sponsored by University of Nevada, Las Vegas.
NCT03722394 is a NA study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03722394, a NA study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
To determine if Pain Neuroscience Education (PNE) would result in positive clinical changes in patients presenting with acute or sub-acute low back pain (LBP).
Primary Outcome
Numeric Pain Rating Scale for Low Back Pain (Range 0 = no pain to 11 = maximum pain)
Interventions
- BEHAVIORAL Pain Neuroscience Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2018-07-30 |
| Phase | NA |
What the finished NCT03722394 record still lists
NCT03722394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Pain Neuroscience Education is the first listed.
NCT03722394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03722394 about?
NCT03722394 is a clinical study titled "Pain Neuroscience Education for Acute and Sub-Acute Low Back Pain". To determine if Pain Neuroscience Education (PNE) would result in positive clinical changes in patients presenting with acute or sub-acute low back pain (LBP).
What is the current status of trial NCT03722394?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-01-10. Estimated completion is 2018-07-30.
What interventions are being tested in trial NCT03722394?
The interventions under investigation include: Pain Neuroscience Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03722394?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03722394's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI